---
schema_version: "secwatch.filing_event.v1"
accession: "0001145197-24-000031"
form_type: "8-K"
ticker: "PODD"
cik: "0001145197"
company_name: "INSULET CORP"
filed_at: "2024-07-26T23:59:59+00:00"
generated_at: "2026-05-31T15:55:15.574671+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Insulet Q2 preliminary revenue $488M (+23% YoY), raises FY Omnipod guidance to 18-21%

## Summary
- Q2 revenue $488M, up 23% YoY, exceeding guidance of 15-18% constant currency growth.
- Total Omnipod revenue $480M (+26%): US $352M (+27%), International $128M (+23%, +24% CC).
- Drug Delivery revenue $8M.
- Raises FY 2024 total Omnipod revenue growth outlook to 18-21% from prior 15-19%.
- Full Q2 results and call scheduled for August 8, 2024.

## SEC filing metadata
- accession: 0001145197-24-000031
- form_type: 8-K
- ticker: PODD
- cik: 0001145197
- company_name: INSULET CORP
- filed_at: 2024-07-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1145197/000114519724000031/0001145197-24-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1145197/000114519724000031/podd-20240726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001145197-24-000031
- JSON: https://secwatch.observer/filing/0001145197-24-000031.json
- Plain text: https://secwatch.observer/filing/0001145197-24-000031.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.